Literature DB >> 5902900

Aplastic anaemia due to phenylbutazone.

A Cameron, A A Eisen, L M Niranjan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5902900      PMCID: PMC2465827          DOI: 10.1136/pgmj.42.483.49

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  THE TREATMENT OF APLASTIC ANAEMIA WITH PHYTOHAEMAGGLUTININ.

Authors:  J G HUMBLE
Journal:  Lancet       Date:  1964-06-20       Impact factor: 79.321

2.  ACUTE LEUKAEMIA ASSOCIATED WITH PHENYLBUTAZONE TREATMENT.

Authors:  H J WOODLIFF; L DOUGAN
Journal:  Br Med J       Date:  1964-03-21

3.  Aplastic anaemia following the administration of phenylbutazone.

Authors:  G S HALE; G C DE GRUCHY
Journal:  Med J Aust       Date:  1960-09-17       Impact factor: 7.738

4.  Aplastic anaemia due to phenylbutazone.

Authors:  G R VENNING
Journal:  Br Med J       Date:  1957-07-20

5.  Toxic effects of phenylbutazone.

Authors:  G D KERSLEY; L MANDEL
Journal:  Lancet       Date:  1953-05-23       Impact factor: 79.321

6.  Toxic effects of phenylbutazone with special reference to disorders of the blood.

Authors:  J C LEONARD
Journal:  Br Med J       Date:  1953-06-13

7.  Pernicious anaemia associated with aplastic anaemia following phenylbutazone therapy.

Authors:  H LANDER; J M BONNIN
Journal:  Med J Aust       Date:  1962-08-25       Impact factor: 7.738

8.  The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use.

Authors:  E F MAUER
Journal:  N Engl J Med       Date:  1955-09-08       Impact factor: 91.245

9.  HEMATOLOGICAL COMPLICATIONS OF PHENYLBUTAZONE THERAPY: REVIEW OF THE LITERATURE AND REPORT OF TWO CASES.

Authors:  D D MCCARTHY; T M CHALMERS
Journal:  Can Med Assoc J       Date:  1964-05-02       Impact factor: 8.262

  9 in total
  1 in total

Review 1.  Aplastic anemia.

Authors:  A S Sethi
Journal:  Indian J Pediatr       Date:  1970-05       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.